Why insider trading matters?
If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.
Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. Humanigen, Inc. was founded in 2000 and is based in Burlingame, California.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-08-12 | Chappell Dale | Chief Scientific Officer | Sell | 167,198 | $17.10 | $2,859,709 | No |
| 2021-07-29 | Chappell Dale | Chief Scientific Officer | Sell | 39,086 | $17.04 | $665,866 | No |
| 2021-07-14 | Chappell Dale | Chief Scientific Officer | Sell | 15,177 | $17.06 | $258,847 | No |
| 2021-07-02 | Chappell Dale | Chief Scientific Officer | Sell | 463,096 | $17.19 | $7,959,379 | No |
| 2021-06-25 | Chappell Dale | Chief Scientific Officer | Sell | 1,272,655 | $17.92 | $22,801,514 | No |
| 2021-06-14 | Durrant Cameron | Chief Executive Officer | Sell | 81,441 | $20.64 | $1,680,934 | No |
| 2021-06-08 | Jordan Edward P. | Chief Commercial Officer | Sell | 14,700 | $20.08 | $295,176 | Yes |
| 2021-06-07 | Chappell Dale | Chief Scientific Officer | Sell | 80,636 | $19.08 | $1,538,793 | No |
| 2021-06-04 | Chappell Dale | Chief Scientific Officer | Sell | 394,364 | $18.52 | $7,304,993 | No |
| 2021-03-09 | NOMIS BAY LTD. | 10%-Owner | Sell | 83,568 | $17.24 | $1,440,495 | No |
| 2021-03-11 | NOMIS BAY LTD. | 10%-Owner | Sell | 235,238 | $16.51 | $3,884,756 | No |
| 2021-03-01 | NOMIS BAY LTD. | 10%-Owner | Sell | 46,505 | $19.02 | $884,432 | No |
| 2021-02-24 | NOMIS BAY LTD. | 10%-Owner | Sell | 103,220 | $22.29 | $2,301,023 | No |
| 2021-02-19 | NOMIS BAY LTD. | 10%-Owner | Sell | 89,408 | $22.25 | $1,989,619 | No |
| 2021-02-13 | NOMIS BAY LTD. | 10%-Owner | Sell | 16,973 | $19.72 | $334,776 | No |
| 2021-02-10 | NOMIS BAY LTD. | 10%-Owner | Sell | 54,273 | $21.61 | $1,172,582 | No |
| 2021-02-04 | NOMIS BAY LTD. | 10%-Owner | Sell | 73,584 | $20.96 | $1,542,363 | No |
| 2021-01-25 | NOMIS BAY LTD. | 10%-Owner | Sell | 95,032 | $19.87 | $1,888,332 | No |
| 2021-01-20 | NOMIS BAY LTD. | 10%-Owner | Sell | 8,500 | $20.29 | $172,423 | No |
| 2021-01-19 | NOMIS BAY LTD. | 10%-Owner | Sell | 105,000 | $18.94 | $1,989,020 | No |
| 2021-01-12 | NOMIS BAY LTD. | 10%-Owner | Sell | 25,000 | $18.67 | $466,650 | No |
| 2020-12-28 | NOMIS BAY LTD. | 10%-Owner | Sell | 500 | $22.20 | $11,101 | No |
| 2020-12-22 | NOMIS BAY LTD. | 10%-Owner | Sell | 50,000 | $20.02 | $1,000,985 | No |
| 2020-12-24 | NOMIS BAY LTD. | 10%-Owner | Sell | 53,401 | $21.24 | $1,134,104 | No |
| 2020-12-22 | NOMIS BAY LTD. | 10%-Owner | Sell | 50,000 | $50000.00 | $2,500,000,000 | No |
| 2020-12-21 | NOMIS BAY LTD. | 10%-Owner | Sell | 87,700 | $16.82 | $1,474,766 | Yes |
| 2020-08-10 | NOMIS BAY LTD. | 10%-Owner | Sell | 17,100 | $5.04 | $86,098 | No |
| 2020-07-28 | NOMIS BAY LTD. | 10%-Owner | Sell | 10,000 | $5.66 | $56,550 | No |
| 2020-07-20 | NOMIS BAY LTD. | 10%-Owner | Sell | 300,000 | $5.00 | $1,500,190 | No |
| 2020-06-30 | NOMIS BAY LTD. | 10%-Owner | Sell | 3,000 | $4.91 | $14,739 | No |
Insider Smart
Insider Smart